NCT03132233View on ClinicalTrials.gov

Energy for the Brain

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 8, 2017

Primary Completion Date

January 16, 2020

Study Completion Date

January 31, 2020

Conditions
MigraineEpisodic Migraine
Interventions
DIETARY_SUPPLEMENT

Beta-hydroxybutyrate calcium and magnesium salt

Exogenous ketone body in mineral salt form.

OTHER

placebo powder

matched placebo powder to the IMP.

Trial Locations (1)

4031

University Children's Hospital (UKBB), Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03132233 - Energy for the Brain | Biotech Hunter | Biotech Hunter